Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer

Clinical trial NCT01426880 · COMPLETED

Trial details

NCT number: NCT01426880
Sponsor: GBG Forschungs GmbH
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Tubular Breast Cancer Stage II Mucinous Breast Cancer Stage II Breast Cancer Female NOS Invasive Ductal Breast Cancer Tubular Breast Cancer Stage III HER-2 Positive Breast Cancer Inflammatory Breast Cancer Stage IV Inflammatory Breast Cancer

Start date: 2011-08-01
Primary completion: 2013-05-01
Enrollment: 595

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.